Allopurinol-induced pyrimidinuria in cancer patients

In Vivo

Volumn 12, Issue 3, 1998, Pages 271-274

  Carducci, Michael A ^a   Choti, Michael ^a   Maestri, Nancy E ^a   Brusilow, Saul W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allopurinol; Cancer patients; Pyrimidinuria

Indexed keywords

ALLOPURINOL; CREATININE; ORNITHINE CARBAMOYLTRANSFERASE; OROTIC ACID; OROTIDINE; PYRIMIDINE NUCLEOTIDE;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE URINE LEVEL; DIAGNOSTIC TEST; DNA SYNTHESIS; ENZYME DEFICIENCY; FEMALE; GENE MUTATION; HUMAN; MALE; URINALYSIS;

EID: 0031825371     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Hauser ER, Finkelstein JE, Valle D, and Brusilow S: Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women. N Engl J Med 322: 1641-1645, 1990. Correction. N Engl J Med 336: 1335, 1997.
2. Burlina AB, Ferrari V, Dionisi-Vici C, Bordugo A, Zacchello F, and Tuchman M: Allopurinol challenge test in children. J Inher Metab Dis 15: 707-712, 1992.
3. Pineda M, Vilaseca MA, Mas A, Fabrega C, and Fernandez AE: Diagnosis of ornithine carbamoyl transferase deficiency and heterozygote detection with allopurinol loading test. Medicina Clinica 101: 383-386, 1993.
4. Kelley WN, and Beardmore TD: Allopurinol: alteration in pyrimidine metabolism in man. Science 169: 388-390, 1970.
5. Fyfe JA, Miller RL, and Krenitsky TA: Kinetic properties and inhibition of orotidine 5′-phosphate decarboxylase. Effects of some allopurinol metabolites on the enzyme. J Biol Chem 248: 3801-3809, 1973.
6. Handschumacher RE: Orotidylic acid decarboxylase: Inhibition studies with azauridine 5′-phosphate. J Biol Chem 235: 2917-2919, 1960.
7. Cardoso SS, Calabresi P, and Handschumacher RE Alterations human pyrimidine metabolism as a result of therapy with 6-azauridine. Cancer Res 21: 1551-1556, 1961.
8. Fallon HJ, Frei E, and Freireich EJ: Correlations of the biochemical and clinical effects of 6-azauridine in patients with leukemia. Am J Med 33: 526-537, 1962.
9. Jeffers LJ, Dubow RA, Zieve L, Reddy L, Reddy R, Livingstone AS, Neimark S, Viamonte M, and Schiff ER: Hepatic encephalopathy and orotic aciduria associated with hepatocelluar carcinoma in a noncirrhotic liver. Hepatology 8: 78-81, 1988.
10. Carducci MA, Nelson JB, Chan-Tack K, et al: Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. Clinical Cancer Res 2: 375-389, 1996.